Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (3): 398-402    DOI: 10.12891/ceog3472.2017
Original Research Previous articles | Next articles
May supplementation of coenzyme Q10 help prevent development of hydatidiform mole?
A. Kolusari1, *(), A. Cebi2, E. Akgun2, H.H. Alp3, E. Bakan4
1 Department of Obstetrics and Gynaecology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey
2 Faculty of Health Sciences, Giresun University Piraziz, Giresun, Turkey
3 Department of Biochemistry, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey
4 Department of Biochemistry, Faculty of Medicine, Ataturk University, Erzurum, Turkey
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  Objective: The pathological mechanisms of gestational trophoblastic disease have not yet been clearly determined. It is thought that oxidative damage contributes to the process. The aim of this study was to determine the levels of coenzyme Q10 (CoQ10), DNA damage, and lipid peroxidation in patients with hydatidiform mole. Materials and Methods: The authors studied the levels of CoQ10, 8-hydroxydeoxyguanosine (8-OHdG), malondialdehyde (MDA) by high-performance liquid chromatography (HPLC), and the activity of glutathione peroxidase (GPX) by spectrophotometric method in blood obtained from patients with a complete hydatidiform mole (n=29), healthy pregnant women (n=29), and healthy non-pregnant women (n=29). Results: The 8-OHdG/dG ratio (2.8148 ± 0.81592) and MDA (10.8341 ± 4.64875 μmol) were significantly higher in patients with complete hydatidiform mole, while the ubiquinol- 10/ubiquinone-10 ratio (0.2107 ± 0.15675) and GPX activity (43.4606 ± 18.31694 mU/ml) were lower (p < 0.001). Conclusion: The authors suggest that both mitochondrial oxidative and oxidative DNA damage play important roles in the pathogenesis of complete hydatidiform mole. Therefore supplementation of CoQ10 prevents recurrent gestational trophoblastic disease.
Key words:  Coenzyme Q10      Ubiquinol      DNA damage      Oxidative stress      Antioxidants      Hydatidiform mole     
Published:  10 June 2017     
*Corresponding Author(s):  A. KOLUSARI     E-mail:  dralikolusari@yyu.edu.tr

Cite this article: 

A. Kolusari, A. Cebi, E. Akgun, H.H. Alp, E. Bakan. May supplementation of coenzyme Q10 help prevent development of hydatidiform mole?. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 398-402.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3472.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I3/398

[1] J. Wang, S.W. Chen, X.Y. Qin, X.Z. Zheng, P. Wang, X.Y. Cai. Clinical application of short tandem repeat polymorphism analysis in the differential diagnosis of early hydatidiform mole and hydropic abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 490-495.
[2] G.L. Liu, S.C. He, W.J. Shan, H.Y. Chen. Repetitive hydatidiform mole in the cesarean scar: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 607-610.
[3] E. Ozbasli, O. Takmaz, H. Gurkan, Y. Alanay, M. Gungor, F. S. Dede. Recurrent hydatidiform mole: when to stop?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 424-426.
[4] J. W. Kim, Y. H. Kim, J. H. Moon, H. A. Jung, E. J. Noh. The efficacy of third-generation cephalosporin plus metronidazole versus third-generation cephalosporin plus clarithromycin in neonatal outcomes and oxidative stress markers in women with preterm premature rupture of membranes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 194-198.
[5] S. Yaman, N. Hançerlioğulları, A. Tokmak, S. Ayhan, M. Alış ık, Ö. Erel. Impaired serum thiol/disulphide homeostasis may be another explanation for the pathogenesis of missed abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 50-54.
[6] E. Rodriguez, J.O. Zamora, I.R. Monfort, L. Rubert, S. Fuster, V. Diago, A. Perales. Unusual twin pregnancy: complete hydatidiform mole with coexistent normal fetus[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 492-493.
[7] S. Akinci, H.Ç. Özcan, Ö. Balat, M.G. Uğur, E. Öztürk, S. Taysi, S. Sucu. Assessment of 8-hydroxydeoxyguanosine levels in patients with preeclampsia: a prospective study[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 226-229.
No Suggested Reading articles found!